Dih Holding Us, INC 8-K filings

Jason Chen has completed his resignation from all roles at DIH Holding US, Inc., including his position as a Board member, effective December 15, 2025.

DIH Holding US, Inc. announced the immediate resignation of CEO Jason Chen, who will remain a board member.

DIH Holding US, Inc. will be delisted from Nasdaq on November 7, 2025, and has suspended operations due to an inability to secure additional capital.

DIH Holding US, Inc. entered into a common shares purchase agreement with an investor for up to $22 million in Class A common stock to fund working capital and general purposes.

DIH Holding US, Inc. announced its fiscal year 2025 financial results, reporting a revenue decrease and negative operating cash flow, alongside significant capital raising activities and a pending Nasdaq listing decision.

DIH Holding US, Inc. announced a 1-for-25 reverse stock split of its Class A Common Stock, effective October 17, 2025, with split-adjusted trading beginning October 20, 2025.

DIH Holding US, Inc. received formal notification from Nasdaq regarding multiple continued listing deficiencies, including market value, bid price, and unfiled reports, leading to a delisting hearing.

DIH Holding US, Inc. received an additional Nasdaq delisting notice for failing to meet the minimum bid price and for overdue financial reports, prompting a hearing request.

DIH Holding US, Inc. stockholders approved a series of proposals including a potential new debenture issuance, conversion price reductions, and a reverse stock split at a Special Meeting.

DIH Holding US, Inc. received an additional Nasdaq delisting notice for failing to meet bid price, market value, and timely filing requirements.

DIH Holding US, Inc. has amended its bylaws to reduce the quorum requirement for stockholder meetings from a majority to one-third of outstanding shares.

DIH Holding US, Inc. announced the appointment of Dr. Barrett Mooney to its Board of Directors, bringing extensive operational and technology scaling expertise.

DIH Holding US, Inc. received a delisting notice from Nasdaq due to failing to meet market value and timely filing requirements, prompting a planned appeal.

DIH Holding US, Inc. received a Nasdaq deficiency notice for failing to timely file its Form 10-Q and Form 10-K, risking its continued listing.

DIH Holding US, Inc. has secured $2.22 million in senior secured convertible debentures and warrants in a private placement, signaling a high-cost capital infusion with significant potential dilution for existing shareholders.

DIH Holding US, Inc. announced the appointment of Scott R. Burell, a seasoned healthcare finance executive, to its Board of Directors.

DIH Holding US, Inc. received a notice from Nasdaq regarding non-compliance due to its failure to timely file its Annual Report on Form 10-K for the period ended March 31, 2025.

DIH Holding US, Inc. announced the appointment of Dennis Streppa to its Board of Directors, where he will also chair the Audit Committee, enhancing the company's corporate governance.

DIH Holding US, Inc. announced the appointment of Professor Nick Ward, M.D., a distinguished expert in neurorehabilitation, to its Scientific Advisory Board, enhancing its commitment to evidence-based innovation.

DIH Holding US, Inc. announced the appointment of Rehazentrum Valens, a prominent Swiss rehabilitation center, as a DIH Center of Excellence, reinforcing their commitment to advancing rehabilitation through innovative robotic technologies.

DIH Holding US, Inc. has amended its Securities Purchase Agreement and Convertible Debenture with an investor, issuing common stock to cover deferred payments and gaining flexibility for future obligations, while the investor waived a default.

Dietmar Dold resigned as Chief Operating Officer of DIH Holding US, Inc., effective June 30, 2025.

Kenneth E. Ludlum resigned from the Board of Directors of DIH Holding US, Inc. effective April 30, 2025.

DIH Holding US, Inc. received a notification from Nasdaq regarding non-compliance with the minimum Market Value of Publicly Held Shares (MVPHS) requirement, granting them until October 1, 2025, to regain compliance.

DIH Holding US, Inc. received a Nasdaq notification regarding non-compliance with the minimum bid price rule, requiring the company to regain compliance by September 8, 2025.

DIH Holding US, Inc. received a notification from Nasdaq regarding non-compliance with the minimum value of listed securities (MVLS) requirement, placing the company at risk of delisting.

Dr. Patrick Bruno resigned from DIH Holding US, Inc.'s Board of Directors and related subsidiary positions, effective February 25, 2025, due to violations of company policies.

DIH Holding US, Inc. reports a revenue decline of 21% for Q3 2025 but reiterates its full-year revenue guidance of $60 to $67 million.

Cathryn Chen resigned from the Board of Directors of DIH Holding US, Inc. effective February 8, 2025, due to her extensive work schedule.

DIH Holding US, Inc. priced a public offering of 5,937,100 common units, each consisting of one share of Class A common stock and one Class A warrant, at a purchase price of $0.7832 per unit.